326 related articles for article (PubMed ID: 28202515)
1. Systematic
Walter DM; Venancio OS; Buza EL; Tobias JW; Deshpande C; Gudiel AA; Kim-Kiselak C; Cicchini M; Yates TJ; Feldser DM
Cancer Res; 2017 Apr; 77(7):1719-1729. PubMed ID: 28202515
[TBL] [Abstract][Full Text] [Related]
2. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
Guan B; Wang TL; Shih IeM
Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
[TBL] [Abstract][Full Text] [Related]
3. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
[TBL] [Abstract][Full Text] [Related]
4. SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis.
Xie Y; Sahin M; Wakamatsu T; Inoue-Yamauchi A; Zhao W; Han S; Nargund AM; Yang S; Lyu Y; Hsieh JJ; Leslie CS; Cheng EH
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810256
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma.
Jiang W; Dulaimi E; Devarajan K; Parsons T; Wang Q; Liao L; Cho EA; O'Neill R; Solomides C; Peiper SC; Testa JR; Uzzo R; Yang H
PLoS One; 2016; 11(10):e0164554. PubMed ID: 27764136
[TBL] [Abstract][Full Text] [Related]
6.
Concepcion CP; Ma S; LaFave LM; Bhutkar A; Liu M; DeAngelo LP; Kim JY; Del Priore I; Schoenfeld AJ; Miller M; Kartha VK; Westcott PMK; Sánchez-Rivera FJ; Meli K; Gupta M; Bronson RT; Riely GJ; Rekhtman N; Rudin CM; Kim CF; Regev A; Buenrostro JD; Jacks T
Cancer Discov; 2022 Feb; 12(2):562-585. PubMed ID: 34561242
[No Abstract] [Full Text] [Related]
7. BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.
Orvis T; Hepperla A; Walter V; Song S; Simon J; Parker J; Wilkerson MD; Desai N; Major MB; Hayes DN; Davis IJ; Weissman B
Cancer Res; 2014 Nov; 74(22):6486-6498. PubMed ID: 25115300
[TBL] [Abstract][Full Text] [Related]
8. Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins.
Köbel M; Hoang LN; Tessier-Cloutier B; Meng B; Soslow RA; Stewart CJR; Lee CH
Am J Surg Pathol; 2018 Jan; 42(1):76-83. PubMed ID: 28863077
[TBL] [Abstract][Full Text] [Related]
9. SWI/SNF inactivation in the endometrial epithelium leads to loss of epithelial integrity.
Reske JJ; Wilson MR; Holladay J; Wegener M; Adams M; Chandler RL
Hum Mol Genet; 2020 Dec; 29(20):3412-3430. PubMed ID: 33075803
[TBL] [Abstract][Full Text] [Related]
10. Chromatin Remodeling Induced by ARID1A Loss in Lung Cancer Promotes Glycolysis and Confers JQ1 Vulnerability.
Liu X; Li Z; Wang Z; Liu F; Zhang L; Ke J; Xu X; Zhang Y; Yuan Y; Wei T; Shan Q; Chen Y; Huang W; Gao J; Wu N; Chen F; Sun L; Qiu Z; Deng Y; Wang X
Cancer Res; 2022 Mar; 82(5):791-804. PubMed ID: 34987057
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric analysis of the phosphorylation levels of the SWI/SNF chromatin remodeling/tumor suppressor proteins ARID1A and Brg1 in ovarian clear cell adenocarcinoma cell lines.
Kimura A; Arakawa N; Hirano H
J Proteome Res; 2014 Nov; 13(11):4959-69. PubMed ID: 25083560
[TBL] [Abstract][Full Text] [Related]
12. BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.
Piva F; Santoni M; Matrana MR; Satti S; Giulietti M; Occhipinti G; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Principato G; Cascinu S; Montironi R
Expert Rev Mol Diagn; 2015; 15(9):1201-10. PubMed ID: 26166446
[TBL] [Abstract][Full Text] [Related]
13. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K
Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162
[TBL] [Abstract][Full Text] [Related]
14. Solid-type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex.
Tsuruta S; Kohashi K; Yamada Y; Fujiwara M; Koga Y; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Cancer Sci; 2020 Mar; 111(3):1008-1019. PubMed ID: 31922331
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
[TBL] [Abstract][Full Text] [Related]
16. Setd2 inactivation sensitizes lung adenocarcinoma to inhibitors of oxidative respiration and mTORC1 signaling.
Walter DM; Gladstein AC; Doerig KR; Natesan R; Baskaran SG; Gudiel AA; Adler KM; Acosta JO; Wallace DC; Asangani IA; Feldser DM
Commun Biol; 2023 Mar; 6(1):255. PubMed ID: 36899051
[TBL] [Abstract][Full Text] [Related]
17. Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development.
Li L; Miao W; Huang M; Williams P; Wang Y
Mol Cell Proteomics; 2019 Mar; 18(3):437-447. PubMed ID: 30487242
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.
Hill DA; de la Serna IL; Veal TM; Imbalzano AN
J Cell Biochem; 2004 Apr; 91(5):987-98. PubMed ID: 15034933
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
Lissanu Deribe Y; Sun Y; Terranova C; Khan F; Martinez-Ledesma J; Gay J; Gao G; Mullinax RA; Khor T; Feng N; Lin YH; Wu CC; Reyes C; Peng Q; Robinson F; Inoue A; Kochat V; Liu CG; Asara JM; Moran C; Muller F; Wang J; Fang B; Papadimitrakopoulou V; Wistuba II; Rai K; Marszalek J; Futreal PA
Nat Med; 2018 Jul; 24(7):1047-1057. PubMed ID: 29892061
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP; Sanchez-Cespedes M
Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]